Close Menu

Amgen

Qiagen Expands Companion Diagnostic Portfolio
Qiagen has received approval of its Therascreen EGFR Mutation Detection Kit RGQ from Japanese regulatory authorities.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Dako said today that it will collaborate with Amgen to develop a diagnostic test for a drug candidate for treating a rare and deadly form of cancer.

This article has been updated to correct a typographical error.

By Turna Ray

The headline and this story have been updated to reflect that BMS and Lilly have submitted to the FDA retrospective analysis on Erbitux's efficacy in colorectal cancer patients with wild-type KRAS mutations, which the agency may use to update the drug label.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Decode Genetics today announced a research collaboration with Pfizer targeting sequence variants associated with specific clinical phenotypes related to systemic lupus erythematosis.

Decode Genetics and Pfizer are collaborating to discover sequence variants associated with clinical phenotypes of systemic lupus erythematosis, Decode said this week.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Warnex today said that it has signed an agreement to serve as exclusive distributor of 10 of DeCode Genetics' tests in Canada.

Pages

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.